Lukatch Heath's Form 4 filing
Vaxcyte, Inc. (PCVX) · filed Jan 12, 2023
- Accession no.
- 0001209191-23-003152
- Filed
- Jan 12, 2023
- Trade date
- Jan 10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $14.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lukatch HeathCIK 0001596385 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2023 | Common Stock | MOption exerciseAcquired | +315 | $16.00 | +$5,040 | 3,440 | Direct | |
| Jan 10, 2023 | Common Stock | SSaleDisposed | −233 | $46.04 | −$10,727.32 | 3,207 | Direct | |
| Jan 10, 2023 | Common Stock | SSaleDisposed | −82 | $46.33 | −$3,799.06 | 3,125 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2023 | Common Stock | MOption exerciseDisposed | −315 | $0.00 | $0 | 28,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.